维普中文期刊产品整合服务
54篇 您的检索式:作者名="Markotic"
    题名 作者 年代 出处 被引量
1Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction显示文摘我们以前在范畴 II 长期的细菌的前列腺炎(CBP ) 表明了 fluoroquinolone-macrolide 联合治疗的安全和功效。这研究的目的是回顾地基于 azithromycin 的联合为 CBP 比较 microbiological 和二个处理计划的临床的调查结果(500   mg,三次每周) 与一次每日的 500-mg 或 ciprofloxacin 的 750-mg 剂量(Cipro-500 或 Cipro-750 队,分别地) 。azithromycin 的联合管理(1500  有以 750   的率的 ciprofloxacin 的 mg 星期 −1) ;为 4 个星期而非在 500   的 mg 天 −1 ;为 6 个星期的 mg 天 −1 从 62.35 % 增加了根除率;到 77.32 %并且从 71.76 % 的全部的细菌学的成功;到 85.57 %。在煽动性的白血球计数和浆液的疼痛和 voiding 症状 / 症状和重要减小地的重要减少前列腺特定的抗原(PSA ) 在两个组在整个 18 月的后续经期被支撑。射精的疼痛, haemospermia 和早泄显著地在两个组在 microbiological 根除上被稀释,但是后者在 Cipro-750 队更即时减退了。总共, 59 个 Cipro-750 病人显示出 mild-to-severe 在基线的可勃起的机能障碍(编辑) ,当 22 个病人没在 microbiological 根除上并且在整个后续时期有编辑时。在结论 fluoroquinolone-macrolide,治疗在病原体根除和 CBP 症状变细导致了,包括疼痛, voiding 骚乱和性机能障碍。为 4 个星期的 ciprofloxacin 的一次每日的 750-mg 剂量与 500-mg 剂量相比显示出提高的根除率和更低的煽动性的白血房间计数 6 个星期。我们的结果是开的推进未来的确认。Vittorio Magri Emanuele Montanari Visnja Skerk Alemka Markotic Emanuela Marras Antonella Restelli Kurt G Naber Gianpaolo Perletti 2011Asian Journal of Andrology2011,13,6:12
2Importance of genetic polymorphisms in liver transplantation outcomes显示文摘Although,liver transplantation serves as the only curative treatment for patients with end-stage liver diseases,it is burdened with complications,which affect survival rates.In addition to clinical risk factors,contribution of recipient and donor genetic prognostic markers has been extensively studied in order to reduce the burden and improve the outcomes.Determination of single nucleotide polymorphisms(SNPs)is one of the most important tools in development of personalized transplant approach.To provide a better insight in recent developments,we review the studies published in the last three years that investigated an association of recipient or donor SNPs with most common issues in liver transplantation:Acute cellular rejection,development of new-onset diabetes mellitus and non-alcoholic fatty liver disease,hepatocellular carcinoma recurrence,and tacrolimus concentration variability.Reviewed studies confirmed previously established SNP prognostic factors,such as PNPLA3 rs738409 for nonalcoholic fatty liver disease development,or the role of CYP3A5 rs776746 in tacrolimus concentration variability.They also identified several novel SNPs,with a reasonably strong association,which have the potential to become useful predictors of post-transplant complications.However,as the studies were typically conducted in one center on relatively low-to-moderate number of patients,verification of the results in other centers is warranted to resolve these limitations.Furthermore,of 29 reviewed studies,28 used gene candidate approach and only one implemented a genome wide association approach.Genome wide association multicentric studies are needed to facilitate the development of personalized transplant medicine.Tomislav Kelava Petra Turcic Antonio Markotic Ana Ostojic Dino Sisl Anna Mrzljak 2020World Journal of Gastroenterology2020,26,12:2
3Surface algorithms using bounds on derivatives显示文摘Filip D Magedson R Markot R 1986Computer Aided Geometric Design1986,3,2:2
4Surface algorithm u-sing bounds on derivatives显示文摘Filip D Magedson R Markot R 0,,04:1
5The Humoral Pattern Recognition Molecule PTX3 Is a Key Component of Innate Immunity against Urinary Tract Infection显示文摘Sébastien Jaillon Federica Moalli Bryndis Ragnarsdottir Eduardo Bonavita Manoj Puthia Federica Riva Elisa Barbati Manuela Nebuloni Lidija Cvetko Krajinovic Alemka Markotic Sonia Valentino Andrea Doni Silvia Tartari Giorgio Graziani Alessandro Montanelli Y 2014Immunity2014,,4:1
6Role of peripheral blood mononuclear (PBMC) phenotype changes in the pathogenesis of hemorrhagic fever with renal syndrome显示文摘Markotic A Dasic G Gagro A 1999Chin Exp Immunol1999,115,:1
7Surface algorithms usingbounds on derivatives显示文摘FILIP D MAGEDSON R MARKOT R 1987Computer Aided Geometric Design1987,3,4:1
8Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome显示文摘Markotic A 2003Acta Med Croatica2003,57,5:1
9Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome显示文摘Markotic A 2003Acta Med Croatica2003,57,5:1
10Surface algorithms using bounds derivatives 显示文摘Filip D Magedson R Markot R 1986Computer Aided Geometric Design1986,3,4:1
11Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome 显示文摘Markotic A 2003Acta Med Croatica2003,57,5:1
12Surface Al- gorithms Using Bounds on Derivatives显示文摘FILIP D MAGEDSON R MARKOT R 1986Computer Aided Geometric Design1986,3,4:1
13Pathogenic hantaviruses elicit different immunoreaetions in THP 1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells显示文摘Markotic A Hensley L Daddario K 2007Coil Antropol2007,31,4:1
14New interval methods for constrained global optimization显示文摘MARKOT M FEMANDEZ J CASADO L CSENDES T 2005Mathematical Programming2005,106,2:1
15Mycoplasm& pneumoni&e in adult community-&cquired pneumoni& incre&ses m&trix met&lloprotein&se-9 serum level &nd induces its gene expression in peripher&l blood mononuele&r ceils显示文摘PuUiz I Markotic A Ovetko KL et &l 2012Med 8ci Moni2012,18,8:1
16Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome显示文摘Markotic A 2003Acta Med Croatica2003,57,:1
17Surface algorithms using bounds on derivatives 显示文摘Filip D Magedson R Markot R 1986Computer Aided Geometric Design1986,3,4:1
18Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome显示文摘Markotic A 2003Acta Med Croatica2003,57,5:1
19Immunopathogenesis of hemorrhagic fever with re- nal syndrome and hantavirus pulmonary syndrome显示文摘Markotic A 2003Acta Med Croatica2003,57,5:1
20Role of peripheral blood mononuclear cell(PBMC) phenotype change in the pathogenesis of haemorrrhagic fever with renal syndrome(HFRS)显示文摘Markotic A Dasic G Gagro A 1999Clin Ex PImmunol1999,115,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费